Process flow for SCM

Regular, accurate information on consumption, drug stock and supplies at the Peripheral Health Institute (PHI), Tuberculosis Units (TUs), districts and state levels are essential for timely drug stock indenting and distribution at all levels.

Drug distribution flow

Under the National TB Elimination Programme (NTEP), the anti-TB drugs are procured at the centre level by the Central TB Division (CTD), Ministry of Health and Family Welfare (MoHFW), and supplied to the central warehouses.

From the central level warehouses, the drugs are supplied to different State Drug Stores (SDS) and further distributed to District Drug Stores (DDS) and sub-district level (TB Unit (TU) Store and Peripheral Health Institute (PHI)).

This movement of drug flow is monitored in real-time through Ni-kshay Aushadhi.

 

Incentives for Private Providers and Informants

Private health providers are an inevitable part of the TB treatment and support in the country. These private providers include:

  • Practitioner / Clinic etc. (Single)
  • Hospital/ Clinic/ Nursing Home etc. (Multi)
  • Laboratories
  • Chemists

 

To improve complete reporting and ensure support care for patients in the private sector, the facilities will receive an incentive of:

Transport Support for TB Patients in Notified Tribal Areas

Special provisions have been made in the tribal, hilly and difficult to reach areas of the country under the National TB Elimination Programme (NTEP) to expand diagnosis and treatment centres, improve access for TB patients and coverage of TB services.

To provide access to diagnosis and treatment centres for people in the tribal areas, NTEP has initiated transport support for TB patients in notified tribal areas from the year 2019.
 

Transport support is available for patients receiving treatment from both the private and public sectors.

Nikshay Poshan Yojana

Nikshay Poshan Yojana (NPY) is one of the four initiative-based support schemes which provides financial support to TB patients for their nutrition. A financial incentive of Rs. 500 per month will be provided to patients on anti-TB treatment till the completion of treatment.

Subscribe to STS